Suppr超能文献

含用于内服的止痛/退热活性成分的非处方药产品;所需酒精警示;最终规则;合规日期。美国卫生与公众服务部食品药品监督管理局

Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS.

出版信息

Fed Regist. 1999 Mar 17;64(51):13066-7.

Abstract

The Food and Drug Administration (FDA) is establishing a compliance date of October 22, 1999, for the regulation that published in the Federal Register of October 23, 1998 (63 FR 56789). The regulation established warning statements that advise consumers with a history of heavy alcohol use to consult a physician for advice about the use of OTC internal analgesic/antipyretic drug products. The compliance date applies to all affected OTC drug products, whether marketed with or without an approved application. FDA is taking this action in response to correspondence and a citizen petition requesting more time to relabel these products.

摘要

美国食品药品监督管理局(FDA)正在为1998年10月23日发布在《联邦公报》(63 FR 56789)上的一项规定设定1999年10月22日的合规日期。该规定制定了警示声明,建议有大量饮酒史的消费者就使用非处方内服止痛/退烧药产品咨询医生意见。该合规日期适用于所有受影响的非处方药品,无论其上市时是否有获批申请。FDA采取这一行动是为了回应相关信件及一份公民请愿书,该请愿书要求给予更多时间来重新标注这些产品。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验